UCA1, which is overexpressed in bladder cancer, specifically induces Glutaminase 2 (GLS2) by sponging miR-16, and can also activate AKT by recruiting E1A Binding Protein P300 (EP300) and lead to bladder cancer cell growth. Here, AKT1 is linked to urinary bladder carcinoma.